中国公众合理用药援助系统
药品查询
请勾选查询条件后检索
药品名 企业名 批准文号 功能主治
你的位置:首页 > 药讯频道 > 药讯 > 医药新闻 > 正文
2 型糖尿病性骨质疏松研究进展
www.yongyao.net  2009-8-25 10:44:34  来源:  责任编辑:
分享到:

参考文献
[1 ]  黄国良,张莹. 糖尿病骨质疏松的评价与对策. 实用糖尿病杂志,2006 ,2 (4) :426
[2 ]  朱翔,章秋. 糖尿病性骨质疏松及其影响因素. 实用糖尿病杂志,2006 ,2 (4) :628
[ 3 ]  Balint E ,Szabo P ,Marshall CF , et al . Glucose2induced inhibition of in vit ro bone mineralization [J ] . Bone ,2001 ,28 (1) :21228
[ 4 ]  章冬梅,吕秀芹,何学峰,等. 胰岛素样生长因子2I 与老年女性糖尿病患者骨密度关系的研究. 中国骨质疏松杂志,2006 ,12(2) :1422144
[ 5 ]  Dominguez LJ ,Muratore M ,Quarta E ,et al . Osteoporosis and diabetes [J ] . Reumatismo ,2004 ,56 (4) :2352241
[ 6 ]  Schwartz AV. Diabetes Mellites :Dose it Affect Bone [J ] . Calcif Tissure Int ,2003 ,73 (6) :5152519
[ 7 ]  Ding KH ,Wang ZZ ,Hamrich MW,et al . Disordered osteoclast formation in RAGE2deficient mouse establishes an essential role for RAGE in diabetes related bone loss. BiochembiophysRes Commun ,2006 ,340 :109121097
[ 8 ]  孔德娟,李恩,佟晓旭,等. 晚期糖化终末产物对人成骨细胞增殖及分泌细胞因子的影响. 中国骨质疏松杂志,2001 ,7 :32
[ 9 ]  Gopalakrishnan V ,Vigneah RC ,Arunakaran J ,et al . Effects of glucose and it s modulation by insulin and est radiol on BMSCdiferentiation into osteoblastic lineages [J ] . Biochem Cell Biol ,
2006 ,84 (1) :932101
[ 10 ]  冯正平,孟萍,陈兵,等. 男性2 型糖尿病患者肾脏损害与骨质疏松症关系的研究. 中国骨质疏松杂志,2003 ,9 (4) : 3382356
[ 11 ]  冯晓丽,孟萍,袁林贵,等. 男性2 型糖尿病合并骨质疏松患者骨生化指标改变. 重庆医学,2005 ,34 (1) :42243
[ 12 ]  Delaney MF. St rategies for t he prevention and t reatment of osteoporosis tality in elderly women [J ] . Am J Obstet Gynecol ,2006 ,194 (2) :S12223
[ 13 ]  Ma X ,Jing Y,Qin W ,et al . Vitamin D receptor gene polymorphism and bone mineral density in patient s wit h type 2 diabetes mellitus[J ] . Chin Med J ( Eng1) ,2001 ,114 (11) :121321320
[ 14 ]  关美萍,薛耀明,张倩,等. 雌激素受体基因多态性与2 型糖尿病患者骨密度的关系. 中国临床康复,2005 ,7 (15) :214022141
[ 15 ]  J e2Tae W,Makoto K,Masanori K, et al . Reveromycin A , an agent for osteoporosis , inhibit s bone resorption by inducing apoptosis specifically in osteoclast s [ J ] . PNAS , 2006 , 103 :
472924734
[ 16 ]  Schwartz AV , Sellmeyer DE , Vit tinghoff E , et al . For t he Healt h , Aging and Body Composition ( Healt h ABC) Study 2006 Thiazolidinedione use and bone loss in older diabetic a2
dult s. J Clin Endocrinol Metab ,2006 ,91 :334923354
[ 17 ]  Ali AA ,Weinstein RA , Stewart SA ,et al . Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation. Endocrinology ,2005 ,146 :122621235
[ 18 ]  La Cava A , Alviggi C , Matarese G. Unravling t he multiple roles of leptin in inflammation and autoimmunity[J ] . J Mol ,2004 ,82 (1) :4211
[ 19 ]  Goxdeladze JO ,Reseland J E. A unified medd fox t he action of leptin on bone turnover [J ] . J Cel1 Biochem ,2003 ,88 (1) :7062712
[ 20 ]  Kanabrocki EL ,Hermida RC ,Wright M ,et al . Circadian variation of serum leptin in healt hy and diabetic men[J ] . Chronobiol Int ,2001 ,18 (2) :2732283
[21 ]  陈敏明,刘云建. 瘦素与骨质疏松研究进展[J ] . 医学理论与实践,2006 ,19 (7) :7732775
[ 22 ]  Browner WS ,Lui L Y,Cummings SR ,et al . Associations of serum of osteoprotegerin levels wit h diabetes ,st roke ,bone density ,f ratures ,and mortality in elderly women[J ] . J Clin Endocrinol Metab ,2001 ,86 (2) :6312637

来源:青岛医药卫生  作者:陈晓红 侯建明

免责声明:本文仅代表作者个人观点,与本网无关。转载目的在于传递更多信息,并不代表本网赞同其观点和对其真实性负责。对本文以及其中全部或者部分内容、文字的真实性、完整性、及时性本站不作任何保证或承诺,请读者仅作参考,并请自行核实相关内容。
返回资讯中心 返回资讯列表